FLUORESCENCE CORRELATION SPECTROSCOPY  TO MEASURE MEMBRANE PERTURBATIONS  THAT AFFECT RECEPTOR-MEDIATED SIGNALING by Palmere, Robert
 
 
  
 
 
 
 
FLUORESCENCE CORRELATION SPECTROSCOPY  
TO MEASURE MEMBRANE PERTURBATIONS  
THAT AFFECT RECEPTOR-MEDIATED SIGNALING 
 
 
 
 
 
 
 
 
 
A Thesis 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Master of Science 
 
 
 
 
 
 
 
 
 
 
by 
Robert Palmere 
May 2018 
 
 
 
ii  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2018 Robert Palmere 
  
 
 
 iii  
 
 
ABSTRACT 
 
 
Diffusion constants (D) and transient confinement times (τ0) of membrane 
bound fluorescent probes thought to partition into liquid-ordered (Lo) or liquid-
disordered (Ld) inner / outer leaflet membrane regions were measured by 
imaging fluorescence correlation spectroscopy.  Resting rat basophilic 
leukemia cells were used under a variety of pharmacological perturbations. 
Yellow Fluorescent Protein-Glycan-Glycosylphosphatidylinositol (YFP-gl-
GPI)was used as the outer-leaflet Lo-like region marker, palmitoyl and 
myristoyl-Enhanced Green Fluorescent Protein (PM-EGFP) was used as the 
inner-leaflet Lo-like region marker, and geranylgeranylated EGFP (EGFP-GG) 
was used as an Ld-like lipid region marker on the inner leaflet. Treatments 
included C2- & C6-ceramide, cholesterol depletion by methyl-beta-
cyclodextrin, 7-ketocholesterol addition, and cytochalasin D.  These membrane 
perturbing treatments were done in efforts to identify a condition in which Lo-
like regions would be disrupted for further study regarding IgE high affinity 
receptor signaling. C6-ceramide treatments showed a propensity to disorder 
Lo-like regions symmetrically for both leaflets of Lo-like domain markers, but 
only resulted in a ~10% decrease in τ0 for Alexa488-IgE-FcεRI without 
significant change in D. Aside from short-chained ceramide treatment, all other 
treatments resulted in either no change, or some degree of increase in τ0 for 
these fluorescent reporters, indicating the local lipid environment as not having 
changed or increased respectively. Asymmetric effects under treatment 
conditions between lipid monolayer Lo-like preferring markers were also 
observed. 
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INTRODUCTION 
 
          The plasma membrane of a cell exists as a boundary between a cell’s internal and 
external environment and plays a critical role in cellular functions. As the primary barrier 
separating external and internal environment of a cell, the plasma membrane also acts as a 
gatekeeper for information exchange via bioactive molecules due to its selective permeability. 
Hence, the plasma membrane is a cell’s first line of defense against external changes and 
facilitates first-response mechanisms relevant to cell insusceptibility to changes in its external 
environment. Due to this variety in function, the plasma membrane must be dynamic enough 
to allow for selective change coinciding with external factors, but if its chemical composition is 
altered then it must be compensated for in order to remain an active barrier. 
           Eukaryotic membranes consist of a lipid bilayer which holds implanted biomolecules, 
including various proteins and carbohydrates. Proteins which are associated with the lipid 
bilayer can be integral or attached via a lipid anchor (Karp, 2010). The lipid bilayer itself is 
amphipathic and encompasses hydrophobic acyl chains each with their respective hydrophilic 
phosphate head group which oppose each other with their hydrophobic fatty acid tails facing 
inward to each other and hydrophilic head groups facing outward towards the cell’s 
environment and cytosolic interior respectively. This organization forms two leaflets of lipid 
monolayers, and it is the combination of hydrophilic phosphate head groups and hydrophobic 
tail interactions that provides the thermodynamic and electrostatic basis for barrier formation. 
Although there are a variety of lipids which compose the lipid bilayer with the primary being 
glycerol based lipids, there are two others worth placing emphasis on due to their ubiquity on 
the plasma membrane: sterols and sphingolipids. 
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            The understanding of biological membranes as having a two-dimensional matrix of 
phospholipids is consistent with the proposal of the fluid mosaic model by Singer and Nicolson 
in 1972 (Singer & Nicolson 1972). However, subsequent developments have increased our 
awareness of a dynamic plasma membrane in-vivo significantly.  Of key importance to these 
developments is the recognition of membrane heterogeneity / asymmetry and its importance 
in live cells.   Along with the variety in lipids constituting the plasma membrane, there exists 
heterogeneity between and within phospholipid monolayers of the outer and inner leaflet 
portions of the lipid bilayer (Fadeel & Xue, 2009). This heterogeneity / asymmetry manifests 
itself in a variety of ways including phase behavior, registration of lipid bilayer inner and outer 
leaflets, and biochemical constituents imbedded between the inner and outer leaflets of the 
bilayer among others (Marquardt, Geier, & Pabst, 2015).  
  
BILAYER LATERAL HETEROGENEITY 
 
The lateral heterogeneity of lipid monolayers can be understood through examination 
of each constituent’s inherent physical properties. The category of glycerophospholipids 
includes lipids such as phosphatidylcholine (PC), which composes more than 50% of plasma 
membrane (Meer, Voelker, & Feigenson, 2008). Glycerophospholipid structure can be 
generalized as having a glycerol ester attached at C-1 and C-2 to two fatty acid chains and C-
3 being attached by a phosphodiester bond which is also attached to a head group. The ester 
carbonyl bond attaching fatty acid chains are not symmetrical in that the C-2 fatty acid is often 
unsaturated containing one cis-isomerization at a particular carbon along the chain. 
Sphingolipids, or, more revealingly named, glycosylceramides, differ from 
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glycerophospholipids in their saturated (trans-) fatty acid chains. The sphingosine base, which 
is generally 18 carbons long, contains a trans- conformation double bond at its C-4,5 bond and 
is bound to its saturated fatty acid chain through an amide bond. 
Cholesterol, is distinctive in its lack of long acyl chains, but rather contains three hexane 
and one pentane rings to form a tetracyclic fused ring. At carbon 3 there exists a hydroxyl 
group and opposing it lies an iso-octyl carbon chain located at C-17.  Cholesterol is vital to cell 
viability and is mostly concentrated at the plasma membrane highlighting its significance 
(Lange, et al., 1989). 
Of primary importance to the understanding of phase behavior, and therefore the lateral 
heterogeneity thereby induced between these three classes of lipids that coexist on the plasma 
membrane, is the packing efficiency, which is dictated by their phosphate headgroups and acyl 
chain conformations (i.e. degree of saturation). Glycerophospholipids experience low melting 
temperature (Tm) due to their inefficient packing of unsaturated acyl chains.  They exist as a 
distribution of molecules in fluid phase, which can be categorized as liquid-disordered (Ld) at 
room temperature (Feigenson, 2009).  
Glycosylceramides and other phospholipids containing saturated, long acyl chains exist 
primarily in liquid-ordered or Lo-like phase on the plasma membrane in-vivo (Munro, 2003). 
The liquid-ordered phase is consists of phospholipids with saturated acyl chains or at most one 
cis-double bond per phospholipid (Fridricksson et al., 1999) and therefore exhibits decreased 
packing efficiency and reduced van-der-Waals and hydrophobic interactions thus permitting 
more lateral movement. 
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The physical properties inherent to Lo and Ld phases on the plasma membrane are 
opportune for studying membrane heterogeneity on the plasma membrane in-vivo as they 
provides means of measuring differences experimentally. For instance, let’s consider a lipid 
bilayer with two phases rigidly segregated (ignoring any entropic expenditure) at a fixed 
temperature. If one is able to measure the displacement of these particular lipids, and the rate 
of their displacement, then one would be able to gain insight into the phase of which each lipid 
constituent is rendered at. Hence, fluidity of the lipid bilayer is important to our understanding 
of the plasma membrane where these two phases can co-exist. The co-existence of Lo and Ld 
in strictly segregated regions of the membrane is not physiologically relevant, but illustrates 
the opportunity for experimental inquiry. Eukaryotic cells exhibit a mixing of these two phases 
at physiological conditions and temperatures. This brings us to the role of cholesterol which is 
pertinent to the investigative objectives of this thesis.  
The structure of cholesterol is predominantly planar due to its tetracyclic backbone 
being in trans- configuration while its carbon chain at C-17 remains relatively flexible. Just as 
above, its chemical structure dictates its sterol-lipid interactions on the plasma membrane.  
Insertion of cholesterol perpendicular to the axis of the plasma membrane which exhibits 
planarity results in orientation of its hydroxyl group toward the extracellular matrix (ECM) 
(aqueous solution interface) and the phosphate head groups of neighboring lipids due 
hydrogen bonding. Hence, cholesterol’s tetracyclic backbone does not reside within the base 
of the opposing acyl chains of its lipid neighbors which constitute the lipid bilayer but rather 
between C2-C10 of acyl chains as shown by previous NMR data (Vist & Davis, 1990). 
Cholesterol interactions, just as its lipid counter-parts, largely depend on the degree of 
saturation of which it is imbedded. Cholesterol’s all trans-carbon ring structured backbone has 
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a large degree of favorable van-der-Waals and hydrophobic interactions with saturated acyl 
chains of glycerophospholipids such as phosphatidylcholine  (PC). The cis-conformation which 
is characteristic of sphingolipids and unsaturated glycerophospholipids such as DOPC effects 
cholesterol packing efficiency and results in a dampening of their hydrophobic effect on 
cholesterol. Rather, the conformational mis-match of cis-conformations rendering kinks in their 
acyl chains can lead to cholesterol exclusion (Pasenkiewicz-Gierula et al., 1991).  In regards 
to phase heterogeneity on the plasma membrane, cholesterol’s critical role is found in its ability 
to form a new phase with its surrounding lipids. This new phase, named liquid-ordered (Lo) 
phase, is not found when examining phase behavior of monolayers of single lipid constituents 
previously named. This new Lo phase can be abstracted as an intermediate phase between 
gel and Ld depending upon the molar ratio of cholesterol and lipid constituents in these two 
phases. This intermediate effect induced by cholesterol is the combination of two differing 
effects on gel and Ld domains (Chen et al., 2007). While cholesterol has a fluidizing effect on 
gel-like domains, it has a packing effect on lipids that compose liquid-disordered regions 
(Schwille et al., 2003). This allows for the Lo phase to be founded on tightly packed interactions 
while enabling increased lateral mobility. The physiological relevancy of cholesterol content 
results in a junction between Lo and Ld phase at intermediate temperatures. This provides the 
cell with adaptability to its membrane dynamics from external sources (i.e. semi-permeable) 
while remaining rigid enough to maintain the established barrier. 
DIFFUSION IN PLASMA MEMBRANE 
 
The fluidity of the plasma membrane is of particular interest in regards to measurement 
of membrane dynamics due to the presence of such heterogeneity. Both lipids and proteins 
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can undergo different types of diffusion which include translational diffusion, rotational 
diffusion, and flip-flopping from one lipid monolayer to the other. With these types of diffusion 
in mind one can narrow the scope of interest to lateral (translational) diffusion due to two 
important factors. Of first and foremost importance is the biological significance of lateral 
mobility for proteins residing on the membrane. As proteins diffuse laterally, they interact and 
diffusion rate can enable or disable a protein from specific sites of signaling (Hoek, et al., 2000). 
The second factor is that the flip-flopping of proteins or lipids is relatively rare and often requires 
enzymes (such as flipase) to catalyze this reaction to overcome the activation energy produced 
by the lipid bilayer itself (Goñi et al., 2010).  
 As diffusivity of proteins has implications for cell signaling, it is important to recognize 
the factors that can control diffusion of a protein on a lipid bilayer.  These factors include 
temperature, degree of saturation of surrounding lipid acyl chains, and the composition of the 
membrane (i.e. protein density, protein-lipid / protein-protein interactions etc.). The 
understanding that the plasma membrane exhibits lateral fluidity was first introduced by Frye 
and Eddin in 1970 (Frye & Edidin, 1970). Since then a discrepancy has been uncovered 
between measured diffusion on model systems in-vitro and slower diffusion measured on the 
live cell plasma membrane by approximately two orders of magnitude (Lee et al., 1993; 
Schmidt et al., 1999). The plasma membrane in-vivo exhibits structural differences with those 
of model in-vitro systems which act to perturb diffusion rates of lipids or proteins laterally. In 
order to rectify these differences, the following models describing plasma membrane 
heterogeneity have been proposed which may not be mutually exclusive. 
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BILAYER LATERAL HETEROGENEITY - RAFT MODEL 
 
The significance of membrane heterogeneity was brought to light over a decade ago 
with the advent of the “lipid raft” hypothesis supported by experimental evidence of detergent 
resistant regions of the plasma membrane (Brown & London, 1997).  A proper definition of lipid 
rafts was decided on at the “Keystone Symposium on Lipid Rafts” held on March 23-28th, 2006 
which is that “rafts are small 10-200 nm, heterogeneous, highly dynamic, sterol- and 
sphingolipid-enriched domains that compartmentalize cellular processes.” (Pike, 2006) This 
model essentially describes the plasma membrane as a dynamic “sea” composed of 
unsaturated phospholipids in fluid phase which contains nanoscopic “rafts” or segments of Lo 
phase laterally segregated from the surrounding disordered phase. This functionally based, 
lateral organization was predominantly discovered by analysis of detergent resistance 
membranes (DRMs) and therefore has outlined the biochemical constituents thought to be 
present in such regions. Brown and Rose found that glycosylphosphadtidyl inositol (GPI) 
anchored proteins, found on the apical membrane surface, are resistant to low density non-
ionic detergent (Triton X-100) at low temperature (0° C) (Brown & Rose, 1992). Whereas, later 
studies have shown these regions to be enriched in cholesterol and sphingolipids (Mayor & 
Rao, 2004).   However, this supporting biochemical evidence and the definition found thereof, 
does not lead to conclusions regarding their definitive existence on the plasma membrane in-
vivo as DRMs are obtained at 0-4°C far below temperatures associated with physiological 
conditions. In addition, solubilization of these “raft”-indicating fractions largely depends on the 
concentration of non-ionic detergent and has been indicated to rearrange the membranes by 
generating Lo phase spontaneously (Heerklotz, 2002). Later methods were employed to gain 
better insight into the plausible existence of rafts closer to physiological conditions which are 
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categorized as model membranes (biomimetic) and consist of Giant Unilamellar Vesicles 
(GUVs) and supported lipid bilayers (SLBs). Although evidence is present for the existence of 
rafts, the definition proposed at the Keystone Symposium is not comprehensive and leaves 
much to be understood.  This general definition does not describe the transient nature of these 
“rafts” which has been indicated to have a range of duration of formation and subsequent 
dissipation (Subczynski & Kusumi, 2003) which is likely dependent upon a multitude of 
biological factors adding to their already complex nature. The size range and factors 
influencing the domain size has also been controversial (Prieto, et al., 2005). Nonetheless, 
these constituent determined ordered domains compartmentalize cellular processes in such a 
way that has functional consequences on proteins which prefer liquid-ordered regions as is 
evident for receptor-mediated signaling in mast cells (Young, Holowka, & Baird, 2003).  
Empirical evidence suggests that it is the coalescence of ordered regions of the plasma 
membrane which induces activation of transmembrane receptors (Sheets, et al. 2007). This 
coalescence is often induced by the cross-linking of proteins or lipids residing on the plasma 
membrane. Lipid rafts have been indicated in a variety of cellular processes, with T-cell 
activation being of pertinent regard in this thesis 
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BILAYER LATERAL HETEROGENEITY – PICKET FENCE MODEL 
 
          Of major influence on plasma membrane dynamics and a critical component of leaflet 
asymmetry is the presence of the cortical actin cytoskeleton. The actin cytoskeleton is a 
dynamic network of polymerized actin filaments and tubules which lies just beneath the inner 
leaflet of the lipid bilayer. It is now well established that the cytoskeleton can have a profound 
effect on the dynamics of membrane lateral heterogeneity and has be implicated in having an 
effect on rafts (Chichili & Rodgers, 2010). Therefore, the actin meshwork that lies beneath the 
cytosolic facing leaflet must be able to control the fluidity of the membrane to perturb purely 
spontaneous phase separation from being a solely dominating force at the plasma membrane. 
This model, named “anchored-protein picket fence”, was first introduced by Kusami and 
colleagues (Kusami et al., 2002). By observing a phospholipid, which is not considered part of 
raft portions, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) fluorescently tagged 
with Cy3 in its phosphate head group was found to be significantly altered by the actin 
cytoskeleton’s degree of polymerization in Large Unilamellar Vesicles (LUVs). No alteration of 
diffusion was found after reduction of the extracellular matrix (ECM) by treatment with trypsin 
nor could the reduction in diffusion be considered raft based as DOPE (1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine) has been implicated as an unsaturated lipid known to exist outside 
nor partition into Lo nanodomains. This rules out the effect of the ECM or rafts acting as barriers 
for diffusion in this model. After treatment with Latrunculin-A (Lat-A), confinement of DOPE 
was found to be less restricted during single particle tracking. Therefore, the “anchored-protein 
picket fence” model suggests that the actin meshwork as the cytosolic face of the plasma 
membrane is the heart of transient confinement of the reduction in diffusion rates found at the 
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plasma membrane. In this model, it has been implicated that transmembrane proteins act as 
binding sites, or “pickets” spanning across the bilayer, tethering the membrane to the actin 
cytoskeleton. The fraction of transmembrane proteins tethered to the action cytoskeleton are 
relatively immobile, which induces a local increase in viscosity of lipids and proteins. In 
addition, these immobile transmembrane proteins act as contact points, or kinetic barriers for 
proteins / lipids that diffuse directly into these protein fractions. Consequently, these “picket” 
transmembrane proteins exclude their immediate membrane areas by causing an increase in 
friction and remain as an immobile barrier of lateral diffusion. The “fence” portions of the model 
are the segmented regions of actin filaments spanning between points of tethered 
transmembrane proteins. These regions are not dependent on cholesterol content and 
therefore remain independent of the traditional effects of “raft”-like domains. Between tethered 
transmembrane proteins and cords of actin filaments, exists free or Brownian diffusion. In the 
case of a protein or lipid diffusing into actin filaments outlining these zones of free diffusion, 
they may or may not have enough kinetic energy to permit crossing into the next confinement 
zone. Diffusion past “fences” or actin meshwork requires “Hop” diffusion where it is thought 
that the actin filament is temporarily dissociated or the protein/lipid diffusing across the 
filamentous barrier possesses enough kinetic energy to overcome the active barrier. The 
“anchored protein picket-fence” model suggests that macroscopic diffusion will express an 
overall decrease in lateral diffusivity depending on the scale of observation. At large 
observation scales (>micrometer) the diffusion shows this general decreased diffusion due to 
filaments and immobile transmembrane proteins, but at the nanoscale, faster free-diffusion will 
be present. 
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BILAYER ASYMMETRY OF LIPIDS / STEROLS 
 
          It is clear that lateral inhomogeneity dictated by phase is distinguished by factors 
including temperature, and interactions between lipid / sterol constituents on the plasma 
membrane. In addition, it has been demonstrated that the cytoskeleton can play an active role 
in mediating protein / lipid diffusion on the plasma membrane. It is also important, in particular 
to the objectives of this thesis, to examine the asymmetry between opposing lipid monolayers 
in the lipid bilayer. The factors which distinguish the two leaflets include the relative abundance 
of certain types of lipids, the influence of the cortical actin cytoskeleton, and distribution of 
cholesterol between the two leaflets. These factors may have a profound impact on the phase 
behavior hypothesized to exist on the plasma membrane. Previous biochemical studies have 
shown there is a disparity between the types of lipids which reside on the inner and outer leaflet 
of eukaryotic plasma membranes. In general, PC and Sphingomyelin (SM) are predominantly 
found at the outer leaflet of the bilayer, while amine attached lipids such as 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS) are 
mostly on the inner leaflet (Feigenson et al. 2008). The differences in the lipid constituents has 
obvious implications for variance in phase behavior between the two leaflets as the lipids 
named have, in general, a higher degree of polyunsaturated carbon tails which reduces 
packing efficiency. With potential difference in Ld phase between the inner and outer leaflets, 
it is important to gain a better understanding of where cholesterol resides between the two 
leaflets. Recent molecular dynamics simulations of the eukaryotic lipid bilayer yield insight into 
a moderately cholesterol enriched outer leaflet with cholesterol distributing asymmetrically 
(~54% and 46% cholesterol content on the outer and inner leaflet respectively (Ingólfsson, et 
al., 2014). This finding implies that the outer leaflet possibly contains an increase in Lo regions 
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compared to the inner leaflet although other hypotheses exist as to the exact partitioning of 
cholesterol between leaflets of the plasma membrane (Devaux & Morris, 2004). 
 This leads to the question of interleaflet coupling and registration between domains of 
the two lipid monolayers which makeup the plasma membrane. This question is critical to 
understanding cellular processes induced by transmembrane signaling proteins which are 
thought to partition into ordered or disordered regions depending on their chemical composition 
(hydrophobic / hydrophilic moieties). Whether or not these domains exist in registry in-vivo and 
to what extent is still not clear. Also, the way in which interleaflet coupling may exist is also 
unknown. Much of our understanding of this depends on molecular dynamic (MD) simulations 
and is rightfully understood through the lens of statistical mechanics.  
 There are a number of theories which are thought to contribute to interleaflet coupling 
which include interdigitation between acyl chains of opposing leaflets, interleaflet cholesterol 
translocation, and surface tension which may or may not be mutually exclusive (Collins, 2008).  
Noteworthy is the experimental and theoretical evidence which suggests that domains formed 
on one leaflet must span the entire bilayer. On the theoretical side, the bilayer mid-plane can 
be thought of as a two-dimensional interface between two liquid phases. These liquids are 
composed of carbons of varying chain length, each of which exhibit line tension with the 
opposing carbons which scale with interfacial area. Although the exact mechanism of coupling 
is not addressed, a free energy term in molecular simulations shows that when a coupling term 
is applied, domains on one leaflet prefer to match the domains in the opposing leaflet to reduce 
an incurring free energy penalty (Putzel & Schick, 2008).  Interleaflet coupling has also been 
demonstrated experimentally in SLBs and unsupported bilayers (Naumann, 2007; Collins & 
Keller, 2008).  In both studies, phase separation on one leaflet could impose phase separation 
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on the opposing leaflet in registration with each other although this is heavily influence by the 
phospholipid ratios constituting each monolayer.  
 Not yet addressed are the influences of membrane curvature on interleaflet coupling. It 
is intuitive that any perturbation to the interfacial line tension present at the bilayer mid-plane 
could have effects on domain registration and leaflet coupling. Neutron scattering experiments 
on unilamellar vesicles (ULVs) composed of ternary mixtures of DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine), DPPC (Dipalmitoylphosphatidylcholine), and cholesterol show an 
increase in curvature (decrease in mean vesicle radius) which results in an increase in the 
fraction of the bilayer composed of Lo domains (Katsaras et al., 2008). Curvature and domain 
registry taken together, can affect miscibility of bilayer constituents.  There lies the possibility 
of affecting phase registration and therefore coupling between lipid monolayers in-vivo 
although no direct experimental evidence of this exists. 
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RBL-2H3 MAST CELL 
 
A cellular model used for studying the plasma membrane is the rat basophilic leukemia 
(RBL) mast cell due to its antigen-induced / antibody-mediated signal transduction pathways.  
A particular example of this is multivalent antigen-mediated Immunoglobulin E (IgE) high 
affinity receptor complex FcεRI.  As mast cells are part of the innate immune system, 
aggregation of IgE-FcεR1 complexes by multivalent antigen results in cellular degranulation 
releasing histamine among other physiologically active amines (Nilsson et al., 2001). FcεRI is 
a native transmembrane protein, and is composed of four subunits which are named α, β, and 
γ2.  The α subunit has both an intramembrane and extracellular portion. The extracellular 
portion of the α peptide has two immunoglobulin-like domains for high affinity binding to the Fc 
fragment of IgE in 1:1 stoichiometry and the extracellular portion of the α subunit is the only 
portion required for binding to IgE (Keown et al., 1995).  The β subunit contains four 
transmembrane domains leading to the two γ polypeptides which form a homodimer linked by 
a disulfide bond which span the membrane and have regions both in the cytosolic and ECM 
(Kraft & Kinet, 2007).  FcεRI is maintained as a tetrameric complex on the bilayer by 
noncovalent and hydrophobic interactions (Kinet, 1999).  Since a large fraction of the FcεRI 
complex and the lipid-anchored proteins, which participate in initial phosphorylation events, 
interact with the hydrocarbon core of the lipid bilayer, it is necessary to investigate the plasma 
membrane of RBL mast cells to characterize the role of the surrounding lipid matrix on the 
receptor.  
Previous studies indicate cross-linked IgE-FcεRI as well as inner-leaflet bound Lyn 
kinase as associating with ordered regions on the plasma membrane through a variety of 
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biochemical and biophysical techniques. Biochemical studies involving cholesterol depletion 
from RBL-mast cells using methyl-β-cyclodextrin (MβCD) have shown a loss of cross-linked 
IgE-FcεRI and Lyn kinase from DRMs under Triton X-100 solubility conditions while outer-
leaflet GPI-anchored proteins, known to partition into ordered-like regions remained intact 
(Sheets, Holowka, & Baird, 1999). It has also been shown that the specific activity of Lyn kinase 
is higher for fractions derived from ordered-like regions (Young et al., 2003). These studies 
suggest that the phosphorylation events of Immunoreceptor Tyrosine-based Activation Motifs 
(ITAMs) after cross-linking by multivalent antigen could possibly be based on the way in which 
Src-family kinases such as Lyn are anchored to the inner-leaflet of the plasma membrane that 
allows partitioning into ordered-like regions could have a significant role in initial signaling 
events. In summary, inherent plasma membrane heterogeneity plays an important role in the 
initial events of mast cell signaling which is further supported by cutting-edge super-resolution 
microscopy investigations in our laboratory (Shelby et al., 2016).  
Previous studies have shown that fluorescently tagged Lyn-kinase colocalizes with 
cross-linked IgE receptors (Holowka, Sheets, & Baird, 2000). The idea that the acyl chain 
anchoring of Lyn could influence co-redistribution with cross-linked receptors was investigated 
further using confocal imaging of live RBL-2H3 cells comparing three green fluorescent protein 
(GFP) constructs with differing acyl chain anchors (Pyenta, Holowka, & Baird, 2001).  Two 
constructs were used:  
 Lyn-EGFP is an endogenous Lyn analog bound to EGFP, PM-EGFP is a 
construct which contains the N-terminal sequence comprising 20 amino acids 
which code for the palmitoyl and myristoyl (PM) acylation sites which anchor it to 
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the inner-leaflet but does not contain its Src-homology 2 (SH2) or other protein 
binding domains 
 EGFP-GG is a construct which has a C-terminal and polybasic sequence similar 
to K-ras, but with modification for geranylgeranylation (GG) as the acyl chain 
anchor to the inner-leaflet.  
 
This previous study shows the colocalization of PM-EGFP with cross-linked IgE 
receptors using fluorescence confocal microscopy, while EGFP-GG shows weaker 
colocalization. The hypothesis that ordered-like regions of the plasma membrane are 
coalesced upon antigen stimulation and therefore functionally relevant to IgE receptor signal 
transduction is supported by the acyl chain anchor dependence of these named Green 
Fluorescent Protein (GFP) constructs. 
Although these previous studies provide strong evidence for ordered regions of the 
plasma membrane playing a crucial role in antigen / antibody mediated signaling, the transient 
nature and size of these hypothesized domains makes them rather elusive to direct 
observation in-vivo.  Equipped with the understanding that the plasma membrane exhibits 
lateral fluidity which differs between ordered and disordered regions, it is desirable to measure 
and quantify these diffusion processes occurring on the plasma membrane to gain insights into 
membrane proteins’ spatiotemporal dependence on membrane fractions that exists in ordered 
or disordered states.  In doing so, the nature of transient nanodomains can be unveiled in their 
relation to receptor mediated signaling and in turn will shed light on the biological relevance of 
these domains on cell signaling processes. 
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FLUORESCENCE CORRELATION SPECTROSCOPY 
 
For the context of this study, the best-fit methodology for measuring plasma membrane 
dynamics in a non-invasive manner is Imaging Total Internal Reflection Fluorescence 
Correlation Spectroscopy (ITIR-FCS). To introduce FCS, let’s first consider particles in solution 
which are in thermal equilibrium and expressing free diffusion (i.e. Brownian Motion). The 
particles will exhibit fluctuations in the distance traveled given a set time.  If the particles are 
distinctly visible in the fixed volume we can certainly count them.  If the particles are left 
unperturbed they will exhibit fluctuations which interrupt the local equilibrium which will be 
dissipated in a characteristic time. One can quantify these local fluctuations using 
autocorrelation functions. Therefore, FCS is a technique used to study the process of diffusion 
where the particles are visualized by their fluorescent properties. Fluorescence intensity of the 
particles from a small observation volume is monitored over time. The intensity trace is 
autocorrelated temporally to generate the autocorrelation function (ACF) which decays with 
time. The characteristic decay time of the ACF is called the diffusion time which is a measure 
of average time particles in solution take to travel across the observation volume. The diffusion 
time is inversely proportional to the lateral diffusion constant (D). The amplitude of the ACF at 
zero lag time is inversely proportional to the number of particles (N) within that observation 
area (i.e., steady state concentration).  
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The principle of the autocorrelation function (ACF or G(τ)) is the measure of self-
similarity of an intensity trace (I(t)) between its beginning and subsequent time off-sets. The 
self-similarity is quantified by the relative overlap of area under the curve of the fluctuations 
from the average intensity trace in a given observation volume at its initial time and that of the 
intensity trace off-set by a subsequent time. Although the ACF function’s full derivation is 
beyond the scope of this thesis, in order to provide a mathematic foundation for understanding, 
the following brief synopsis of the ACF function is provided.  
The temporal fluctuations in intensity trace from the average renders the equation: 
𝛿𝐼(𝑡) = 𝐼(𝑡) − 〈𝐼(𝑡)〉  
The general form of G(τ) is given as the following: 
𝐺(𝜏) =  
〈𝐼(𝑡)𝐼(𝑡 + 𝜏)〉
〈𝐼(𝑡)〉2
 
This general form of the ACF assumes stationarity of temporal fluorescence which can be 
shown mathematically as the following equation: 
〈𝐼(𝑡)〉2 = 〈𝐼(𝑡)〉〈𝐼(𝑡 + 𝜏)〉2 = 〈𝐼(0)〉2 where 𝑡, 𝜏 = 0 
By making subsequent substitutions using the definition of temporal intensity fluctuations as 
well as making accurate assumptions, a more reduced form the general ACF formula can be 
obtained. Ignoring the normalizing denominator and substituting our definition of I(t) gives: 
𝐺(𝜏) =  
〈(𝛿𝐼(𝑡) + 𝐼(𝑡))(〈𝐼(𝑡 + 𝜏)〉 + 𝛿𝐼(𝑡 + 𝜏))〉
〈𝐼(𝑡)〉2
 
Expanding the numerator we find: 
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=
〈𝐼(𝑡)〉2 + 〈𝛿𝐼(𝑡)𝛿𝐼(𝑡 + 𝜏)〉 + 〈𝐼(𝑡 + 𝜏)〉〈𝛿𝐼(𝑡)〉 + 〈𝐼(𝑡)〉〈𝛿𝐼(𝑡 + 𝜏)〉
〈𝐼(𝑡)〉2
 
By recognizing the temporal fluorescence fluctuation does not change (stationarity) and by 
dividing the denominator into the numerator as indicated we find the following equation: 
= 1 +
〈𝛿𝐼(𝜏)𝛿𝐼(0)〉
〈𝐼(𝑡)〉2
 
 
Where 𝐼(𝑡) and 𝛿𝐼(𝜏) can be written in the following way: 
𝐼(𝑡) =  𝜅 ∫ 𝑊(𝑟)𝐶(𝑟, 𝑡)𝑑𝑟
∞
−∞
 
𝛿𝐼(𝜏) =  𝜅 ∫ 𝑊(𝑟)𝛿𝐶(𝑟, 𝜏)𝑑𝑟
∞
−∞
 
𝜅 denotes brightness, 𝑟 is the spatial coordinate, t is time, 𝐶(𝑟, 𝑡) is the concentration at 
spatial coordinate 𝑟 and time t. 𝑊(𝑟) describes the observation volume and can be 
approximated as Gaussian and contains the product of the intensity profile of the focused 
excitation beam 𝐼(𝑟) and the fluorescence at position 𝑟 after spatial limits being applied by 
the microscope pinhole.  
𝑊(𝑟) = 𝐼0𝑒
−
2𝑥2
𝜔02𝑒
−
2𝑦2
𝜔02𝑒
−
2𝑧2
𝜔𝑧2 
Where the ωo and ωz represent the beam waist lengths in their respective axes as indicated 
by numerator variables, and 𝐼0 is the maximum intensity at the focal point of the beam. 
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Substituting the Gaussian approximation expression for 𝑊(𝑟) into expressions for 𝐼(𝜏), one 
can represent average temporal fluorescence in the following way after integration over all 
coordinates: 
〈𝐼(𝑡)〉 = 𝜅 ( 
𝜋
2
)
3
2
𝐼0𝜔0
2𝜔𝑧∫ 𝐶(𝑟, 𝑡)𝑑𝑟
∞
−∞
 
Substituting expressions found for 〈𝐼(𝑡)〉 and 𝛿𝐼(𝜏) back into the general ACF one can 
simplify to render: 
𝐺(𝜏) =  
1
〈𝐶〉2
∙
8
(𝜋
3
2𝜔02𝜔𝑧)
2∫ ∫ 𝑊(𝑟)𝑊(𝑟′)〈𝐶(𝑟, 0)𝛿𝐶(𝑟′, 𝜏)〉𝑑𝑟𝑑𝑟′
∞
−∞
∞
−∞
 
〈𝐶(𝑟, 0)𝛿𝐶(𝑟′, 𝜏)〉 = 〈𝐶〉 ∙ 𝑒−
(𝑟−𝑟′)2
4𝜏𝐷 ∙ 8−1(𝜋𝜏𝐷)−
3
2 
Where the expression provided for  〈𝐶(𝑟, 0)𝛿𝐶(𝑟′, 𝜏)〉 can be derived from Fick’s laws of 
diffusion, and D represents the diffusion constant. 
After substitution of 〈𝐶(𝑟, 0)𝛿𝐶(𝑟′, 𝜏)〉 back into 𝐺(𝜏), and recognizing the definition of effective 
focal volume in confocal microscopy (𝑉𝑒𝑓𝑓 =
(∫𝑊(𝑟)𝑑𝑟)2
∫𝑊2(𝑟)𝑑𝑟
) one can arrives at the ACF for a 3D 
system: 
𝐺(𝜏) = 1 +
1
𝑁
(1 +
4𝜏𝐷
𝜔02
)
−1
(1 + (
4𝜏𝐷
𝜔02
) (
𝜔0
𝜔𝑧
)
2
)
−
1
2
 
Equation 1.  ACF for Confocal Microscopy 
 
 21 
 
Where N represents the average number of particles within the observation volume and can 
be extracted from the amplitude of the autocorrelation function 𝐺(0). 
ILLUMINATION BY TOTAL INTERNAL REFLECTION 
  
 To illuminate molecules at the membrane and to improve signal to noise ratio (SNR), it 
is desirable to control the incidental light used to fluoresce molecules such that only 
fluorophores located at or near the membrane are excited. This can be achieved through total 
internal reflection fluorescence (TIRF) which produces an evanescent wave at the ventral 
membrane and in turn illuminates molecules located at the membrane surface.  
When light travels from one medium to another, Snell’s law states that the incidental 
light angle and the refractive index of the first medium the light passes through is proportional 
to the refractive index of the second medium and the angle of refraction. This is mathematically 
stated in Snell’s Law of Refraction as 𝑛1 sin 𝜃1 = 𝑛2 sin 𝜃2 where 𝜃1and 𝜃2 are the incidental 
and refractive angles of the light and 𝑛1 and 𝑛2 are the indices of refraction for first and second 
mediums respectively. 𝑛1 sin 𝜃1 can also be referred to as the numerical aperture (NA) of the 
microscope objective that is used to focus the incident light at the sample.  In order for the 
incidental light from an optically dense medium to reflect away from the boundary axis it has 
with a rarer medium, it must have an angle larger than what is known as the critical angle (θc). 
The critical angle can be found from Snell’s Law of Refraction as  
𝜃𝑐 =  𝐴𝑟𝑐𝑠𝑖𝑛 (
𝑛2
𝑛1
) 
Equation 2.  Snell’s Law of Refraction 
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Therefore, the angle of incidental monochromatic light used to excite fluorescent 
molecules located at the membrane must be greater than or equal to that of θc. The incidental 
light coming from an optically denser medium does not propagate through the rarer medium 
when the incident angle is greater than the critical angle. However, the electromagnetic field 
of light is not discontinuous at surface plane of the two medium and will produce a non-
propagating evanescent wave in the rarer medium. The intensity of the evanescent wave, 
however, decays exponentially along the z-axis (parallel to the optical axis of incident light) of 
the two mediums (Breuer et al., 2008). This exponential decay along the z-axis is expressed 
using the following equation: 
𝐼(𝑧) = 𝐼𝑜𝑒𝑥𝑝(−
𝑧
𝑑
) 
Equation 3.  Exponential decay along the z-axis 
 
Where the function I(z) is the intensity of the evanescent wave at a given z-axis position from 
rarer medium, Io is the intensity of the evanescent  
 The distance of which the evanescent wave penetrates is found by the following expression: 
𝑑 =
𝜆𝑖
4𝜋𝑛1
(𝑁𝐴2 − 𝑛2
2)−
1
2 , 𝑁𝐴 = sin 𝜃1𝑛1 
Equation 4.  Distance of which the evanescent wave penetrates 
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Where λi is the wavelength of incidental monochromatic light used to excite fluorophores. The 
penetration depth along the z-axis of the evanescent wave field is particularly pliable to 
increase SNR and limit the depth to that of the width of the cell membrane. From the above 
equation, one can see that increasing the NA will reduce the penetration depth either by 
adjusting the angle of light from the denser medium or by increasing its index of refraction. 
Hence, mineral oil is used as the immersion medium of the objective in all experiments 
contained in this study for high refractive index (1.518). 
The ACF derived above for confocal microscopy differs from that of the ACF fitting function 
used for TIRF microscopy in that 𝐺(𝜏) for the TIRF case is 2-D and involves determination of 
the effective area by convolution of microscope point spread function (PSF) with the size of 
CCD chip of the camera at the object plane, which has been recently developed. For the full 
derivation please see (Bag, 2014 & Sankaran 2012). 
𝐺(𝜏) =  
1
𝑁
(
 
 erf (𝑝(𝜏))+
(𝑒−(𝑝(𝜏))
2
−1)
√𝜋𝑝(𝜏)
erf(
𝑎
𝜔0
)+
𝜔0
𝑎√𝜋
(𝑒
−
𝑎2
𝜔0
2
−1)
)
 
 
2
+ 1 ;  𝑝(𝜏) =  
𝑎
√4𝐷𝜏+ 𝜔𝑜2
 
Equation 5.  ACF for TIRF Microscopy 
In this expression, 𝝎𝒐 represents the lateral portion of the observation volume (just as in 
equation 1), 𝝉 is the lag time, 𝑫 is the diffusion constant, and 𝒂 represents the pixel side 
length. 
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FCS DIFFUSION LAW 
 
In addition to fitting using the ACF, the FCS diffusion law is also an important tool 
for extracting data for FCS measurements to gain information regarding membrane 
heterogeneity below diffraction limit.  It works to uncover this information based on 
principles of spot variation FCS. The FCS diffusion law provides a description of the 
dependence of time for a particle diffusing through an effective area (𝜏𝐷) on the effective 
area of the system (A). Rather than making multiple measurements at various sizes of 
effective areas as is found in spot variation FCS performed in other FCS modalities, 
Imaging FCS (IFCS) used in this study performs effective area changes to show  𝜏𝐷 
dependence on effective area (A) post-acquisition of image file by binning the pixels 
intensity values. This removes the requirement of multiple measurements of variable spot 
sizes. In this thesis, pixel binning between 2x2-5x5 pixels are performed to achieve optimal 
statistics. After plotting multiple points of 𝜏𝐷 as a function of effective area (A), a linear fit 
on the data can be performed to acquire the value of the y-intercept, the 𝜏0 value. The  𝜏0  
value reveals the dynamics observed on the membrane which are associated with various 
nanoscale structural determinants. For unhindered, Brownian diffusion, this linear equation 
should render a 𝜏0 value of 0 as D is space-invariant. In the case of anomalous diffusion 
caused by nanodomains or cytoskeletal interference, D will vary as the effective area 
increases such that 𝜏0 values will be positive or negative (“hop” diffusion), respectively 
(Wawrezinieck et al., 2005).  
The mathematical expression for the diffusion law of FCS measurements is: 
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𝜏𝐷(𝐴) =
𝐴
4𝐷
+ 𝜏0 
 Equation 6.  Diffusion Law for FCS measurements 
   
 Here, the 𝜏𝐷 are the experimentally determined times of diffusion at an effective area A. 𝜏0 
is the extrapolated time of diffusion at A = 0 using Weighted Least Squares (WLS) 
regression. The effective area, A, in the case of IFCS, is a result of the convolution of the 
point spread function (PSF) with the pixel area (pixel side length squared) at the object plane 
which details the actual area of the membrane being observed.   
Please see the Materials and Methods section on page 30 regarding how 𝐷 and 𝜏𝐷 
parameters are obtained from experiments conducted in this study. 
THE PRESENT STUDY 
 
With the evidence from previous experiments that the IgE receptor likely exists in an 
order-preferring lipid environment on the plasma membrane, it is necessary to further 
investigate the plasma membrane’s effect on the IgE signaling pathway (Holowka et al., 2005). 
Evidence of the IgE receptors signaling dependence relying on the coalescence of ordered 
regions on the plasma membrane can be acquired by inducing disorder in an otherwise 
ordered domain and examining the biological effects of this change. Imaging FCS provides the 
means to observe the effect caused by obstacles for various fluorescently tagged proteins 
which exist in more or less ordered-like environments on each leaflet of the membrane. As 
previously indicated, these obstacles may be ordered-like nanodomains, but also may be 
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caused by actin filaments, both expected to induce a general decrease in diffusion constant 
(D) and increase in transient confinement (τ0) of the proteins being observed.  
The present study compares plasma membrane anchored proteins two of which (YFP-
gl-GPI and PM-EGFP) are thought to partition into Lo-like domains and one believed to partition 
into less ordered regions, EGFP-GG, (Ld preferring) located on the outer and inner leaflet of 
RBL-2H3 mast cells under a variety of membrane constituent perturbing pharmacological 
conditions (Veatch et al., 2017; Baumgart et al., 2007; Simons et al., 2010). Each treatment 
condition is made in an attempt to disorder the otherwise ordered regions of the RBL plasma 
membrane and to observe the effects these treatments have on each leaflet of the bilayer. The 
pharmacological perturbations made to cultured RBL-2H3 cells include removal of cholesterol 
by use of methyl-β-cyclodextrin and integration short chain ceramides (C2- and C6- ceramide) 
or 7-ketocholesterol in the membrane. These conditions will be discussed in detail in the 
upcoming results and discussion chapters. 
MATERIALS AND METHODS 
 
 Cell Culture.  RBL-2H3 cells were maintained in monolayer culture as previously 
described (Pierini et al., 1996), and harvested using trypsin-EDTA (Life Technologies, 
Rockville, MD) 3-4 days after passage.  Cells were cultivated in DMEM (Dulbecco’s Modified 
Eagle Medium; Invitrogen) supplemented with 20% FBS (fetal bovine serum) and 1% 
streptomycin at 37°C in 5% (v/v) CO2 humidified environment. 
 Sample Preparation and Transfection. Plasmid constructs including YFP-gl-GPI, 
palmitate and myristate-EGFP, and EGFP-geranyl geranyl were prepared previously as 
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described (Pyenta et al., 2001).  Cultivated RBL-2H3 cells were seeded into glass covered 
dishes (35 mm Petri dish, 14 mm Microwell, No.  1.0 cover glass (0.13–0.16 mm), MatTek 
Corporation, Ashland, MA) containing 2 ml cell Dulbecco’s Modified Eagle Medium (DMEM) + 
20% FBS and incubated overnight. Stocks of anti-DNP (anti-2,4-dinitrophenyl) IgE labeled with 
Alexa-488 and unlabeled, were prepared as described (Subramanian et al., 1996). For labeling 
of FcεRI, labeled and unlabeled IgE was diluted in 1 ml Tyrodes buffer (4 M NaCl / 1M KCl / 
0.5M MgCl2 / 0.5M CaCl2 / 1M Glucose / 1M HEPES in  ddH2O, pH 7.4) at 2 μg / ml of a 1:3 
molar ratio (labeled and unlabeled respectively) and incubated with cells for 40 min. at room 
temperature (~22°C) then washed twice with 2 ml Tyrodes buffer prior to treatment  In the case 
that transfection was required, cells were transfected in their respective glass covered MatTek 
dishes using 0.25 μg / μl plasmid, the appropriate amounts of FuGENE HD Transfection 
Reagent (Promega Corporation, Madison, WI) (6 μg / μl plasmid) and 100 μl Opti-MEM 
(ThermoFisher Scientific, US) per glass covered dish being used.  After incubation with 
transfection reagents, cells were washed with 1 ml cell culture medium and then incubated in 
2 ml cell culture medium 12-24 hours prior to imaging.  Immediately prior to imaging, cell culture 
medium was discarded, washed twice with 2 ml Tyrodes buffer and replaced with 2 ml Tyrodes 
buffer.  Pharmacological treatments by incubation subsequently described were performed in 
1 ml Tyrodes prior to wash and replacing 2 ml Tyrodes buffer before imaging. 
 Methyl-β-Cyclodextrin Treatment.  Cell culture tested, methyl-β-cyclodextrin (MβCD) 
was purchased from Sigma-Aldrich (US, Lot# 59H1082).  A 20 mM MβCD stock solution was 
made in Tyrodes buffer and frozen between uses (-20°C).  Reduction in concentration of MβCD 
was achieved by serial dilution prior to treatment in Tyrodes buffer shortly before conducting 
the measurements. 
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 C2- & C6-Ceramide Treatments.  C2- and C6-ceramide stock solutions were prepared 
at 22.5 mM and 5.5 mM in ethanol and DMSO solvent respectively.  Prior to treatment, a small 
glass vial was prefilled with 1 ml Tyrodes buffer solution containing 1 mg / ml bovine serum 
albumin (BSA) prior to aliquots of ceramide being added for the desired concentration for cell 
exposure.  After subtle mixing, the 1 ml Tyrodes + ceramide was added to MatTek dish pre-
seeded with cells and containing 2 ml Tyrodes + BSA. It was then incubated at room 
temperature for 10 minutes prior to subsequent imaging. Imaging sessions for a single 
treatment typically extended for ~1 hr. 
 7-Ketocholesterol / MβCD Complex Preparation and Treatment.   
7-Ketocholesterol (7-KC) was purchased from Sigma-Aldrich (US). 5% (w/w) MβCD stock 
solution was prepared by dissolving 250 mg of MβCD in 5 ml ddH2O.   Next, 1 ml of 15 mg / 
ml 7-KC was prepared in a glass vial.  400 μl of stock MβCD was added to a high-performance 
liquid chromatography (HPLC) vial on a hotplate at 80°C with occasional mixing.  4 x 10 μl 
aliquots of 7-KC/ethanol solution was added drop-wise to the HPLC vial allowing for 5-10 
minutes to pass with occasional mixing.  After the final (fourth) aliquot of 7-KC/ethanol solution, 
the HPLC vial was left on the 80°C hotplate for one hour without covering the vial to evaporate 
the majority of ethanol solvent.  After one hour, the HPLC vial was covered, and stored at 4°C.  
Cells were treated with 15 μl 7-KC:MβCD complex diluted in 1 ml Tyrodes buffer solution at 
room temperature and incubated for 30 minutes at 37°C prior to imaging. 
 Cytochalasin D Treatment.  Cytochalasin D (Aldrich Chem. Co., Milwaukee, WI) was 
kept at a stock solution of 1.95 μg / ml in DMSO. Cytochalasin D stock solution was 
subsequently diluted ~1:1000 in order to reach a concentration of 2 μM in Tyrodes buffer 
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solution. 1 ml of 2 μM Cytochalasin D solution was then aliquoted into MatTek dishes pre-
seeded with RBL-2H3 cells and incubated at 37°C for 5 minutes prior to imaging at room 
temperature (~22°C). 
 Imaging Fluorescence Correlation Spectroscopy.  Imaging of all samples was 
carried out at room temperature (~22°C) using a Leica DMIRB Inverted Confocal Microscope 
and a high NA oil immersion objective (100x, NA 1.47). For illumination of endogenous or 
synthetic fluorescently labeled proteins, a 488 nm Coherent Sapphire (Santa Clara, CA) laser 
was used.  The laser beam was directed into the microscope by a combination of tilting angle 
mirrors after its intensity was attenuated by a neutral density filter to achieve optimal signal to 
noise ratio with minimal photobleaching.  The incidental laser beam was then focused onto the 
back focal plane of the objective after reflection by a dichroic mirror. The objective immersion 
oil used was Olympus Type-F (refractive index of 1.518).  Total Internal Reflection (TIR) was 
acquired via the last tilting mirror prior to the laser being directed into the microscope that of 
which the position could be changed steadily.  The microscope was connected to an Andor 
iXon+ fast electron multiplying charge coupled device (EMCCD) camera through a side port.  
Image acquisition was done through Andor SOLIS software using an exposure time of 3.0 ms 
and kinetic series length of 80,000 frames.  Regions of interest (ROIs) were specified generally 
in the middle of each cell measured, with a given pixel range usually at 40x40.  Data were 
stored as 16-bit .TIFF files. 
Under the circumstance of defocusing during measurements, the protocol was altered 
in order to circumvent this problem in the following way: the kinetic series length was lowered 
to 20,000 frames and performed four times while holding the same ROI size and position 
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provided by the Andor SOLIS software. These 20,000 frame image stacks were then 
concatenated through ImageJ software to compose a single 80,000 image stack.  
 FCS Data Analysis.   Image series were saved as black and white 16-bit .TIFF files 
and intensity values for each pixel underwent temporal correlation using ImageJ plugin 
“ImFCS” software (available at http:// staff.science.nus.edu.sg/~chmwt/ImFCS.html) in order 
to obtain the autocorrelation functions (ACFs) of each pixel / binning within the ROI specified.  
Using the acquired ACF data, the “ImFCS” plugin fits the data using non-linear least squares 
regression for best fit of Equation 5 (ACF for TIRF Microscopy).  All parameters are provided 
by the user for the fitting equation (except those which remain as fit parameters including N 
and D ). After best fitting of the ACF data using equation 5 within the “ImFCS” software, the 
diffusion constants obtained are directly extracted. The FCS Diffusion Law provided in equation 
6 is performed in the following manner within the “ImFCS” software: the pixelwise diffusion 
constants are obtained for various effective areas by binning of pixel intensities after which the 
diffusion constants are averaged. Once the average diffusion constant is obtained for the 
specified ROI, it is used as a constant in the diffusion law plot. In this case, the time of diffusion, 
τD, in equation 6 is not directly extracted from the ACF, but is provided by recognizing that 
4𝐷
𝐴
=
 𝜏𝐷 when 𝜏0 = 0  (i.e. free diffusion) where D is the obtained average and A is the effective area 
obtained depending on pixel side length. Pixels were defined using a 2-5 binning scheme as 
this was found to be an optimal approach.  A 2x2-5x5 binning was used for ROIs spanning 7x7 
individual pixels (1x1) using default overlapping mode for improved statistics (Bag et al., 2016). 
In this manner, the diffusion law analysis is conducted by plotting data points of calculated 𝜏𝐷  
as a function of effective area (A) and using weighted least squares regression to obtain the 
𝜏𝐷 intercept (𝜏0). Batch fitting of data from the exported Excel sheet by ‘ImFCS’ was done using 
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home-built code written in MatLab for multiple weighted least squares regression (WLS) where 
weights were approximated using the Standard Error of the Mean (SEM).  See Appendix A. 
 Statistical Analysis.  Statistical analysis was performed using Matlab’s Statistics and 
Machine Learning Software package (MathWorks Natick, MA).  After determination of non-
normality by a quantile/quantile plot of the data, a Mann-Whitney U test was implemented to 
estimate the statistical significance of results compared to control. 
RESULTS 
          For the purpose of identifying pharmacological conditions which have the ability to disrupt 
cholesterol-dependent liquid-ordered regions on the resting RBL-2H3 cell membrane, the 
transient confinement time (τ0) and diffusion constants (D) exhibited by various membrane-
bound proteins were measured using imaging total internal reflection fluorescence correlation 
spectroscopy (ITIR-FCS). The following results section includes three types of graphical 
representations of data collected in this study: 
1) Average D and τ0 values (y-axes) obtained per cell (colored box markers) as well the 
total average for all trials (black empty square marker) of a particular protein and 
treatment as indicated by the x-axis (e.g. Figure 1). Error bars denote the standard error 
of the mean (SEM). Total averages for all trials (9-10 cells) per protein / treatment ± 
standard deviation (SD) are provided in each table (e.g. Table 1). 
2) Histograms of D and τ0 values represent the combined distribution of D and τ0 from all 
trials of a given fluorescent reporter and treatment condition (e.g. Figure 3). As indicated 
by their headers, histograms and their corresponding horizontal bar graph sets (below 
each histogram) are separated by the fluorescent reporter they represent and the 
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treatment series performed. These histograms are normalized by area for their direct 
comparison to other treatments also represented on the same axes.  
3) Horizontal bar graphs, located below each histogram, are another way of direct 
comparison of the data presented in each histogram compared to their respective control 
distributions. Each horizontal bar graph is representation of the fraction of data points 
collected which exhibit either D or τ0 values above or below ± 1 SD of the control 
distribution, and, in the case of τ0, also the fraction of data points which hold a value 
below 0. The fraction of data points which are values greater than +1 SD from the mean 
of the control data set are represented by red color bars, and are regarded as the fraction 
of molecules contributing to “fast” diffusion in the case of D and “long” transient 
confinement time in the case of τ0. Likewise, the gray bars represent the fraction of data 
points which are values below -1 SD from the mean of the control distribution and are 
regarded as “slow” diffusion or “short” transient confinement time. Yellow bars represent 
the fraction of data points contributing to the bulk of the data.  As explained on page 24,  
green represents the fraction of molecules expressing “hop” diffusion which 
encompasses the fraction of data points holding τ0 values below 0. Each horizontal bar 
set is representative of the histograms it is located under. 
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Effects of Short-Chain Ceramides on Lo Fluorescent Reporters 
 
          In order to reveal the effects on translational mobility by short-chain ceramides (C2- and 
C6-ceramide) on ordered regions of the lipid bilayer of RBL-2H3 cells, τ0 and D values were 
obtained for RBL-2H3 cells transfected with outer-leaflet ordered region preferring protein 
YFP-GPI and inner-leaflet ordered region preferring PM-EGFP. Data collected for average τ0 
and D values per cell under these conditions are plotted for visualization of significant changes 
induced by treatment with ceramide compared to the control population in Figures 1 & 2. A 
significant increase in translational diffusion for YFP-GPI was found for treatment with 16 μM 
C6-ceramide (~ +33%) corresponding with a decrease in τ0 (~16%) indicating increased fluidity 
and decreased lipid order caused by C6-Ceramide integration at outer-leaflet Lo-like regions 
under these conditions. However, incubation with 32 μM C2-ceramide resulted in significant 
decrease in τ0 without significantly effecting the average D for YFP-GPI. These results are 
consistent with previous findings using FRET (Förster Resonance Energy Transfer) and 
fluorescence anisotropy where it was observed that C6-ceramide is more potent on a mole-
per-mole basis than C2-ceramide at disordering cholesterol-dependent ordered regions of the 
lipid bilayer on RBL-2H3 cells (Gidwani et al., 2003). The effects of C2- and C6-ceramide at 
inner-leaflet ordered regions by PM-EGFP were also observed for comparison. Treatment with 
32 μM C2-Ceramide showed no statistically significant change in average D of PM-EGFP just 
as in the case of YFP-GPI, but additionally showed no change in average τ0.  This result is 
rather surprising considering that there exists a high probability of short-chain ceramide 
translocation across the lipid bilayer after integration in the plasma membrane (Bai & Pagano, 
1997). In order to extract information regarding subtle changes which may be less discernable 
when comparing the obtained averages of D and τ0 in these cases, distributions of these data 
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are presented in Figures 3, 4, 5 and 6. The distribution of D for PM-EGFP broadens as a result 
of C2-ceramide treatment (Figure 5) expressing an increase in the variability for diffusion under 
this condition. In the case of C6-ceramide treatment, the τ0 distribution does not change for 
PM-EGFP. YFP-GPI shows ~10% reduction in molecules exhibiting long transient confinement 
time (>+1 Standard Deviation) which corresponds with the 16% decrease in average τ0 as 
mentioned. Interestingly, both YFP-GPI and PM-EGFP show an increase in their fractions of 
fast moving particles (~15 and 20% respectively) (Figures 3 & 5), but only YFP-GPI shows a 
corresponding increase in short transient confinement time (<-1 Standard Deviation) (Figure 
4, gray bar).  
          To further investigate the fluidizing effect of C6-ceramide on Lo-like regions, the diffusion 
properties of Alexa488-IgE-FcεRI were observed by incubation with Alexa-488 labeled anti-
DNP IgE prior to treatment with 16 μM C6-ceramide as described in Materials and Methods. 
C6-ceramide had no effect on the diffusion of Alexa488-IgE-FcεRI despite the symmetric 
increase observed for YFP-GPI and PM-EGFP (Figure 7). As shown in Figure 8, the 
distribution of τ0 for Alexa-488-IgE-FcεRI under C6-ceramide treatment shows a shift 
consistent with the ~10% decrease in average value. Average values from all experiments 
performed using short-chain ceramides are summarized in Table 1. 
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Table 1.  Summary of average results obtained from imaging FCS measurements on resting RBL-2H3 cells 
incubated with 32 μM C2- and 16 μM C6-ceramide in Tyrodes buffer solution (± SD) 
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Figure 1. Effects of C2- & C6-ceramide on average D  Figure 2. Effects of C2- & C6-ceramide on average τ0  
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Figure 3. Effects of C2- & C6-ceramide on YFP-GPI D 
Distributions      
Figure 4. Effects of C2- & C6-ceramide on YFP-GPI  τ0 
Distributions 
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Figure 5. Effects of C2- & C6-ceramide on PM-EGFP D 
Distributions            
Figure 6. Effects of C2- & C6-ceramide on PM-EGFP τ0 
Distributions 
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Figure 7. Effects of C6-ceramide on Alexa488-IgE-FcεRI D 
Distributions 
Figure 8. Effects of C6-ceramide on Alexa488-IgE-FcεRI τ0 
Distributions 
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Effects of Cholesterol Depletion  
on Inner and Outer Leaflet Lo / Ld Fluorescent Reporters 
 
          For the purpose of examining the relative effect of cholesterol depletion between 
monolayers, MβCD was incubated with resting RBL-2H3 cells for 30 minutes at 37°C 12-24 
hours after transfection with either YFP-GPI or PM-EGFP plasmid constructs as described in 
Materials and Methods. Cholesterol removal by incubation with MβCD resulted in a significant 
decrease in average D and increase in τ0 values for both YFP-GPI and PM-EGFP, but not for 
EGFP-GG (Figure 9, blue markers and Table 2). This decrease in lateral mobility exhibited by 
YFP-GPI and PM-EGFP and lack-thereof for EGFP-GG in a cholesterol depleted lipid 
environment is consistent with previous findings in this laboratory, namely that cholesterol 
depletion under these conditions causes the formation of ventral plaques (observed very close 
to bottom surface of the cell) containing Lo preferring proteins such as YFP-GPI and PM-EGFP, 
but not Ld preferring proteins such as EGFP-GG, and that these plaques exhibit a significant 
reduction or complete loss of lateral mobility as measured by Fluorescence Recovery After 
Photobleaching (FRAP) experiments (D. Holowka, unpublished observations). However, the 
relative changes in values obtained by FCS measurements indicate asymmetry between 
ordered regions on the outer and inner leaflets. While the D and τ0 values for both reporters 
decrease and increase respectively, there is a stark contrast in the magnitude of change (Table 
2) where lateral mobility is more restricted for YFP-GPI than for PM-EGFP. By looking at the 
normalized distributions of these data (Figures 11, 12, 13 & 14), it is apparent that the decrease 
in average diffusion is caused by an increase in the fraction of molecules presenting slow (< -1 
SD from the mean) diffusion and long confinement time (> +1 SD from the mean). Notable is 
the lack of any change in average D by EGFP-GG (Figure 9) which is consistent with their lack 
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of partitioning into ventral plaques formed after cholesterol depletion (D. Holowka, unpublished 
observations). While the average D does not change in a cholesterol depleted environment, the 
distribution (Figure 15) for D values is broadened. Additionally, the distribution of τ0 values 
(Figure 16) shows an increase in average contributed by an increase in fraction of EGFP-GG 
molecules with longer transient confinement times (see discussion). 
 
 
Effects of 7-Ketocholesterol 
on Inner and Outer Leaflet Lo / Ld Fluorescent Reporters 
 
          In the continued search for a suitable pharmacological treatment which would adequately 
disrupt cholesterol-dependent ordered regions on the RBL-2H3 cell plasma membrane, MβCD, 
preloaded with 7-ketocholesterol (7-KC) (1:1 molar ratio), was incubated with RBL-2H3 cells to 
incorporate 7-KC in the lipid bilayer. Such treatment is known to laterally disorder plasma 
membranes in Jurkat T cells. The addition of 7-KC on the RBL-2H3 plasma membrane however 
showed no significant change in average D obtained for YFP-GPI (outer-leaflet), but did induce 
an increase in average τ0 (Figures 9 & 10). The normalized distribution of D values also shows 
no change from that of the control (Figure 11, red line), while that of τ0 values indicates an 
increase in the fraction of YFP-GPI molecules exhibiting longer confinement times and a 
reduction in short confinement times (Figure 12). These observations are disparate with those 
found for inner-leaflet markers PM-EGFP and EGFP-GG. There is a significant uniform 
decrease in average D (~15%) for both PM-EGFP and EGFP-GG induced by 7-KC addition 
(Figure 9 & 10). Although the average τ0 values increase for both of these reporters, the extent 
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of which varies between the two with PM-EGFP increasing by ~64% and EGFP-GG nearly 
doubling (Table 2). The normalized τ0 distributions for these proteins show increased long 
transient confinement time (Figures 14 & 16), although perhaps to a lesser extent for PM-EGFP 
(red bars). A combination of treatments were performed in succession, first adding MβCD for 
cholesterol depletion and then addition of 7-KC as described in materials and methods (see 
discussion). D and τ0 values were restored to closer to control levels in the case of YFP-GPI 
compared to that of only treatment with MβCD and reach an intermediate in long transient 
confinement between 7-KC and MβCD treatments alone (Figures 9 & 10, blue compared to 
green markers for YFP-GPI). This same set of succession of treatments had a different effect 
on PM-EGFP, where fraction of slow diffusing and long-transient confinement of PM-EGFP 
molecules was increased further than either 7-KC or MβCD treatments alone, which was not 
the case for EGFP-GG (Figures 14 & 16) 
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Table 2.  Summary of average results obtained from imaging FCS measurements on resting RBL-2H3 cells incubated with MβCD, 
7-KC, or MβCD then 7-KC in Tyrodes buffer solution (± SD). 
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Figure 9. Effects of Cholesterol Depletion & 7-KC Addition on 
D Averages 
Figure 10. Effects of Cholesterol Depletion & 7-
KC Addition on τ0 Averages 
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Figure 11. Effects of Cholesterol Depletion & 7-KC Addition 
on YFP-GPI D Distributions 
Figure 12. Effects of Cholesterol Depletion & 7-
KC Addition on YFP-GPI τ0 Distributions 
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Figure 13. Effects of Cholesterol Depletion & 7-KC Addition 
on PM-EGFP D Distributions 
Figure 14. Effects of Cholesterol Depletion & 7-
KC Addition on PM-EGFP τ0 Distributions 
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Figure 15. Effects of Cholesterol Depletion & 7-KC Addition 
on EGFP-GG D Distributions 
Figure 16. Effects of Cholesterol Depletion & 7-
KC Addition on EGFP-GG τ0 Distributions 
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Effects of Cytochalasin D 
on Inner and Outer Leaflet Lo / Ld Fluorescent Reporters 
 Lastly, to assess the role of the actin cytoskeleton in controlling lipid ordering indicated 
by these fluorescent probes, actin polymerization was inhibited by incubation with 2 μM CytoD 
for 5 minutes at room temperature. No significant change for either D or τ0 values obtained for 
YFP-GPI (Figures 17 & 18). However, PM-EGFP expressed a significant increase in the 
fraction of slow D and long transient confinement time as shown by the normalized distribution 
of these values (Figures 21 & 22). These effects were not observed for EGFP-GG, but rather 
a broadening of these distributions was found (Figures 23 & 24). Also, unlike that of EGFP-
GG, a substantial increase in the fraction of EGFP-GG molecules exhibiting hop diffusion 
(Figure 22, green bar) was also found. Data are summarized in Table 3. 
 49 
 
 
Table 3.  Summary of average results obtained from imaging FCS measurements on resting RBL-2H3 cells incubated with 2 μM CytoD 
in Tyrodes buffer solution. 
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Figure 17. Effects of CytoD on D Averages Figure 18. Effects of CytoD on τ0 Averages 
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Figure 19. Effects of CytoD on YFP-GPI D Distributions Figure 20. Effects of CytoD on YFP-GPI τ0 Distributions 
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Figure 21. Effects of CytoD on PM-EGFP D Distributions Figure 22. Effects of CytoD on PM-EGFP τ0 Distributions 
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Figure 23. Effects of CytoD on EGFP-GG D Distributions Figure 24. Effects of CytoD on EGFP-GG τ0 Distributions 
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DISCUSSION 
          The results from the present study provide experimental evidence of the relative effect 
of which a variety of pharmacological perturbations have on the inner- and outer- leaflets of 
the RBL-2H3 cell lipid bilayer. Each of these treatments, which include exogenous addition 
of short-chain ceramides, MβCD, 7-KC, and Cytochalasin D (CytoD), were implemented in 
efforts to identify a potential treatment which would render Lo-like regions of the resting RBL-
2H3 cell membrane into that of Ld for further study on the role of these hypothesized domains 
in relation to IgE high affinity receptor FcεRI signaling. A significant body of work has been 
developed in regard to these various treatments which provides ample background and 
reasoning for their implementation in this study which will be referenced throughout this 
discussion.  
 Sphingolipids play a substantial role in constituting the lipid bilayer and have been shown 
to be biologically active signaling molecules (Okazaki et al., 1989). By action of 
sphingomyelinase, sphingomyelin located at the plasma membrane is hydrolyzed to render 
ceramide which has been indicated in regulating a plethora of biological processes including 
mediation of immune response (Kolesnick et al., 2002).  The chemical structure of ceramides 
is that of a sphingosine backbone covalently attached to a fatty acid of varying acyl chain 
length via an amide bond. In order to perturb the effect of endogenous, long-chain ceramides 
induced to be present at the plasma membrane, cell permeable short-chain, (C2-C6 fatty 
acid acyl chain) ceramides are used. Previous work in the Baird-Holowka laboratory has shed 
light on the ability of exogenous addition of short-chain ceramides in generating disorder at 
the lipid bilayer in-vitro and in-vivo. Steady-state fluorescence anisotropy measurements of 
membrane vesicles extracted from RBL-2H3 cells have shown evidence of the lipid 
disordering capability of C2- and C6- ceramide where C6-ceramide was more potent in 
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decreasing anisotropy (which means a more disordered nature of the plasma membrane) 
when compared to that of C2-ceramide. In the same study, C2- and C6- ceramide were found 
to disrupt raft structure in-vivo as indicated by Förster resonance energy transfer (FRET) 
where it was found that both C2- and C6- ceramide decreased FRET between Cy3-labeled 
anti-Thy1 bound Thy1 (GPI-anchored ordered region marker) and Alexa488-IgE bound FcεRI 
indicating their ability to disrupt Lo-like region structure (Gidwani et al., 2003). These 
observations encouraged us to use short chain ceramides as potential candidates for 
Imaging FCS measurements to test the modulations of plasma membrane organization. 
          In the present context of measurements conducted by imaging FCS, exogenous 
addition of C2- ceramide resulted in transbilayer asymmetric effects between Lo-like region 
preferring fluorescent reporters on either leaflet of the lipid bilayer. While diffusion remained 
unchanged for outer-leaflet marker, YFP-gl-GPI, the distribution of PM-EGFP exhibits 
increased variability. In addition, there exists no significant change in transient confinement 
time for PM-EGFP while that of YFP-gl-GPI decreases. These findings suggest that C2-
ceramide treatment by exogenous addition to resting RBL-2H3 cells does not affect Lo-like 
regions of the lipid monolayers at the plasma membrane in proportion to one another. Rather, 
C2-ceramide disorders outer-leaflet Lo-like domains as shown by a decrease in transient 
confinement time of YFP-GPI, but does not change lipid order for inner-leaflet Lo-like regions. 
It is not likely that this is attributed to C2-ceramide being localized solely at outer-leaflet Lo-
like domains as the probability of C2-ceramide transbilayer movement is high. It is more 
probable that these asymmetric trends are an expression of the difference in phospholipid 
species and cholesterol content which inherently exists between lipid monolayers in-vivo. 
Short and long acyl chain ceramides have previously been shown to exclude cholesterol from 
cholesterol-dependent Lo-like domains in-vitro (Megha & London, 2004; Schwille et al., 
 56 
 
2006). Although the exact location(s) of cholesterol at the plasma membrane is controversial, 
recent experimental evidence of cholesterol occupying a lower mole fraction at the 
cytoplasmic face of the lipid bilayer has been found in HeLa cells using orthogonal lipid 
sensors (Liu et al., 2017). The lack of change in order as indicated by transient confinement 
time of PM-EGFP under C2-ceramide treatment conditions may be caused by this lack of 
cholesterol content at the cytoplasmic face of the membrane in RBL-2H3 cells. This lack of 
change in order as indicated by PM-EGFP transient confinement is reinforced by data 
collected for C6-ceramide treatments, despite its increased potency for lipid disorder inducing 
effects on a mole-per-mole basis compared to that of C2-ceramide for outer-leaflet Lo-like 
region marker YFP-GPI. Clearly, there exists a coupling between monolayers as indicated 
by the symmetric increase in diffusion constants obtained for treatment with C6-ceramide on 
outer- and inner-leaflet fluorescent reporters despite asymmetric lipid disordering effects. It 
is likely that this coupling in diffusion for these domain markers is caused by the high rate of 
flip-flop of C6-ceramide between the two monolayers. In combination, these data support the 
perspective of short-chained ceramides increasing membrane fluidity rather symmetrically 
between lipid monolayers while the disordering effects may be localized to the outer-leaflet 
possibly due to a higher abundance of sterols located at the outer-leaflet (and thus a higher 
fraction of ordered regions at the outer leaflet in unperturbed cells). To further investigate this 
discrepancy between monolayers, the effects of C6-ceramide integration on the plasma 
membrane were observed directly for transmembrane protein Alexa488-IgE-FcεRI. 
Intriguingly, C6-ceramide caused no increase in lateral diffusion constants compared that of 
the control, while still inducing a decrease in transient confinement time. The lack of change 
in diffusion is likely caused by the substantial increase in mass and volume of which the 
FcεRI complex contains / occupies compared to that of the GPI anchor and palmitate-
myristate anchor of YFP-GPI and PM-EGFP respectively. The magnitude of reduction in 
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order of the local lipid environment for FcεRI is similar to that found for YFP-GPI (~11% and 
~16% reduction in average τ0 value respectively) is predominantly influenced by C6-
ceramides ability to disorder outer-leaflet Lo-like regions as previously discussed. 
          Methyl-beta-cyclodextrin (MβCD) is a common drug used for cholesterol depletion at 
the plasma membrane. These oligosaccharide heptamers are structurally cyclical, and have 
the highest affinity for cholesterol at their hydrophobic core in comparison to their α and γ 
counterparts (Pitha et al., 1989).  Previous work in the Baird-Holowka laboratory has shown 
a loss of association of both Lyn kinase and cross-linked FcεRI with DRMs isolated after 
TritonX-100 treatment and decreased tyrosine phosphorylation of FcεRI by Lyn kinase 
suggesting the criticality of their localization in cholesterol-dependent Lo-like domains for 
initial steps in FcεRI signaling (Sheets, Holowka, & Baird, 1999). The effect of MβCD on the 
three fluorescent reporters used in this study sheds light on the consequences of cholesterol 
depletion on lipid order and fluidity in-vivo. Under a cholesterol depleted lipid environment 
induced by MβCD, there is global increase in transient confinement exhibited by both Lo 
inner- and outer-leaflet reporters as well as Ld preferring inner-leaflet reporter EGFP-GG. 
This provides evidence for a global increase in gel-like lipid phase caused by cholesterol 
depletion at the membrane of RBL-2H3 cells. These results are surprising, considering a 
previous in-vivo FCS study which has been conducted using other cell types which show the 
expected decrease in lipid order as result of cholesterol removal from Lo regions (Bag, 
Huang, & Wohland, 2015). The cause of such a result is not fully understood, but this 
increase in order indicated by these membrane anchored probes may be cell line dependent 
(Huang et al., 2016), perhaps even unique to the RBL-2H3 plasma membrane. Intuitive to 
increased confinement time is the decrease in diffusion constants found for Lo-like region 
reporters. However, this change is not exhibited for EGFP-GG, but rather a broadened 
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distribution of D. The implications of this result are unclear, although it is likely that inner-
leaflet lipid reorganization by cholesterol depletion results in a less structurally 
accommodating local lipid environment, expunging the sterically hindered geranylgeranyl 
anchor of this probe from partitioning into these newly formed domains. 
          7-ketocholesterol (7-KC) is an oxysterol derivative of cholesterol which has been 
shown to intercalate into Lo-like regions of membranes in-vitro by analysis of DRM yield 
(Massey & Pownall, 2005). The disordering properties of 7-KC, namely their ability to convert 
Lo regions to that of Ld has been demonstrated in Jurkat-derived T cells and HeLa cells by 
generalized polarization of Laurdan labeled cells and fluorescence-lifetime imaging 
microscopy (FLIM)-FCS respectively (Gaus et al. 2012; Rentero et al., 2008). The results 
found in this study provide contrasting evidence despite following the same methodology for 
exogenous addition of 7-KC to resting cells. Just as in the case of cholesterol depletion, a 
global increase in long transient confinement time was found while effects to diffusion 
constants differed between inner- and outer-leaflet probes indicative of increased lipid order 
rather than the expected decrease. The discrepancy between the membrane disordering 
effects reported for 7-KC addition and the results presented in this study are difficult to 
reconcile. However, these results do support the notion that the RBL-2H3 membrane exhibits 
unusual characteristics compared to other cell lines. Due to the increased polarity of 7-KC 
and its decreased packing efficiency, 7-KC has been shown to have a rate of translocation 
between lipid monolayers orders of magnitude faster than cholesterol (Vila et al., 2001). 
Therefore, it is not likely that the overall increase in membrane order / decreased fluidity of 
inner-leaflet probes is due to fixed localization of 7-KC at the inner-leaflet although it cannot 
be ruled out that it may exist in higher molar ratios at the inner-leaflet under these treatment 
conditions. In fact, recent experimental evidence suggests exogenous addition of cholesterol 
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to the plasma membrane of HeLa cells is asymmetrically distributed resulting in no significant 
increase in cholesterol found at the outer-leaflet, but a 73% increase of inner-leaflet 
cholesterol (Liu et al., 2017). Hence, the asymmetric effects observed by 7-KC addition 
between leaflets may be due to the method of delivery to the plasma membrane by MβCD 
rather than a lack in the ability for 7-KC to induce symmetric effects if delivered efficiently to 
both lipid monolayers using a different approach. 
          The contrast between outer- and inner-leaflet probes under 7-KC addition spurred 
inquiry of whether 7-KC affected the relative abundance of cholesterol between monolayers 
which could possibly perturb lipid order. Therefore, a combination of treatments was used 
first by incubating with MβCD for cholesterol depletion and then 7-KC addition. Under these 
conditions, a restorative effect towards, although not reaching, control diffusion and transient 
confinement time was observed for YFP-GPI. This reinforces evidence found regarding 7-
KC occupancy of ordered lipid environments in-vivo. Additionally, these results provide a 
context in which 7-KC induces disorder at the outer-leaflet, namely, after new domains form 
by cholesterol depletion. This combination of treatments provided an even larger fraction of 
PM-EGFP molecules exhibiting long-time transient confinement while less was found for 
EGFP-GG. These findings lend aid to the notion that it is 7-KC itself that induces increased 
lipid order and that its interactions with phospholipids at these ordered regions enables this 
condensation. 
          Due to the cytoskeleton’s role in actively regulating membrane fluidity and lipid 
organization at the plasma membrane, CytoD was tested. CytoD is a common 
pharmacological treatment for inhibiting active actin polymerization in-vivo by its ability to 
arrest polymerization at the barbed end of actin filaments (Cooper, 1987). No evidence of 
change was observed for YFP-GPI under actin inhibited conditions, although statistically 
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significant change was observed for PM-EGFP and to a lesser extent EGFP-GG. The lack in 
difference between treated and control for YFP-GPI agrees with previous FCS 
measurements of COS-7 cells observing GFP-GPI under these same treatment conditions 
(Lenne et al. 2006). In contrast to the outer-leaflet, the increased order induced at the inner 
leaflet for both Lo and Ld markers provides evidence for the actin cytoskeleton’s role at 
regulating inner-leaflet membrane order. The significant increase in transient confinement by 
PM-EGFP compared to that of EGFP-GG lends further evidence to the notion that the 
cytoskeleton is localized at ordered regions (Wu et al., 2004).  Data for PM-EGFP under 
CytoD treatment conditions suggest an increase in local lipid order, although reasons for this 
remain unclear considering the opposite effect has been found for inhibition of actin 
polymerization by CytoD using other Lo-like fluorescent reports in other cell types (Adkins et 
al. 2007). 
The body of evidence provided in this study by imaging FCS measurements does not 
implicate the majority of the employed pharmacological perturbations to be effective at 
disrupting Lo-like regions on the resting RBL-2H3 membrane. Rather, these perturbations 
often indicated an increase in phospholipid order to some degree although this effect varied 
depending on the targeted lipid environment by these fluorescent reporters. However, C2 
and C6-ceramides were found to disrupt outer-leaflet Lo-like regions, with C6-ceramide being 
more effective on a mole-per-mole basis. The results of this study also highlight the 
asymmetry of effects exhibited by these treatments between Lo-like regions of lipid 
monolayers in-vivo, which may have implications for findings regarding IgE receptor-
mediated signaling when observed using similar treatment conditions. 
The root cause of increased lipid order by these treatments in RBL-2H3 cells, contrary 
to the expected and experimentally demonstrated decrease in lipid order in other models, 
 61 
 
remains to be determined. Further insights might be gathered by changing the 
pharmacological perturbations used to reach a similar desired effect. For instance, in this 
study MβCD was used to directly extract and deplete the membrane of cholesterol in-vivo, 
but a similar effect could possibly be achieved by inhibition of de novo synthesis of cholesterol 
in the RBL-2H3 cell by other drugs such as mevastatin. In this way, pleiotropic effects by 
MβCD may be identified when compared. As lipid phase properties are largely controlled by 
cholesterol content it would be desirable to monitor cholesterol content between leaflets 
under these various conditions perhaps by means of fluorescently labeled cholesterol in 
combination with fluorescence quenchers. 
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APPENDIX A - MATLAB CODE FOR MULTIPLE WEIGHTED LEAST SQUARES (WLS) 
REGRESSION 
In order save significant time during analysis, the following MATLAB code was developed to 
automate the acquisition of the intercept values (τ0) from the diffusion law over sub-regions 
of the image.  
“ImFCS” plugin for FIJI was used to produce the excel sheets containing data consisting of 
τD values for each iteration of binning (2-5) within the ROI.  
This MATLAB code enables a linear fitting and storage of τ0 values using WLS where the 
weights are 1/SEM from these excel files. 
The SEM is calculated by extracting standard deviation values provided by “ImFCS” 
software, and allows the user to enter the number of observations (N) which depends on the 
ROI and pixel area of the .TIFF image stack.  
 
xlfile_dir=uigetdir; 
cd(xlfile_dir); 
dir_vec=dir([xlfile_dir, '\*.xlsx']);%generate vector of directory .xslx files 
filenames = {dir_vec(:).name}.';%file names must have same number of characters 
  
for i = 1:length(dir_vec(:)) 
      fullname = [xlfile_dir filesep dir_vec(i).name];         
Excel = actxserver('excel.application'); 
Excel.workbooks.Open(fullname,0,true); 
sheets=Excel.ActiveWorkBook.Sheets; 
sheetdifflaw=get(sheets,'Item',20); 
sheetdifflaw.Activate; 
nCols = Excel.ActiveSheet.UsedRange.Columns.Count; 
nRows = Excel.ActiveSheet.UsedRange.Rows.Count; 
Excel.Quit 
Excel.delete 
pause(0.1); 
tksc(i,:)=char(filenames(i)); 
[num]=xlsread(tksc(i,:),'DiffLaw Map SD'); 
v=1:nCols-1;%iterates through column count for DiffLaw Map SD 
stdeviation=num(:,v); 
Nvalue=[, , , ,]; %Comma separated list of N’s in decreasing order from left to right provided by user (for 1-
5 binning) 
        for kdx=1:5 
        weight(kdx,v)=(stdeviation(kdx,v)./(Nvalue(kdx)).^0.5).^-1; 
        end 
[tt]=xlsread(tksc(i,:),'DiffLaw Map Data'); 
x=tt(2:5,1);%extracts single column vector for x (2-5 binning) 
j=2:nCols; 
y=tt(2:5,j);%array for all y-intercepts 
s=sum(weight(2:5,v)); 
sx=sum(weight(2:5,v).*x); 
sy=sum(weight(2:5,v).*y); 
sxx=sum(weight(2:5,v).*x.^2); 
sxy=sum(weight(2:5,v).*x.*y); 
delta=s.*sxx-(sx).^2; 
a=(sxx.*sy-sx.*sxy)./delta; 
b=(s.*sxy-sx.*sy)./delta; 
Results.slope=b;%generate construct containing all calculated slopes 
Results.Intercept=a;%generate construct containing all calculated y-intercepts 
y_fit=a+b.*x; 
 resizea=a(:); 
 vec{i}=resizea; 
End 
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